Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Clinical Pharmacology in Drug Development
|
December 8, 2022
Clinical Drug-Drug Interaction Between Vatiquinone, a 15-Lipoxygenase Inhibitor, and Rosuvastatin, a Breast Cancer Resistance Protein Substrate
Lucy Lee, Katsuyuki Murase, Jiyuan Ma, et al.
European Journal of Clinical Pharmacology
|
September 27, 2022
Evaluation of vatiquinone drug-drug interaction potential in vitro and in a phase 1 clinical study with tolbutamide, a CYP2C9 substrate, and omeprazole, a CYP2C19 substrate, in healthy subjects
Katsuyuki Murase, Lucy Lee, Jiyuan Ma, et al.
Journal of Clinical Pharmacology
|
September 23, 2024
Determination of Vatiquinone Drug-Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
Lucy Lee, Noriko Okudaira, Katsuyuki Murase, et al.
Biopharmaceutics & Drug Disposition
|
September 16, 2025
Enhanced Vatiquinone Bioavailability With Fatty Meals and Optimal Dosing Schedule
Lucy Lee, Katsuyuki Murase, Martin Thoolen, et al.
Chemistry & Biology
|
March 6, 2003
EF-Tu binding peptides identified, dissected, and affinity optimized by phage display
Katsuyuki Murase, Kim L Morrison, Phillip Y Tam, et al.
ACS Chemical Biology
|
July 3, 2007
Double barrel shotgun scanning of the caveolin-1 scaffolding domain
Aron M Levin, Katsuyuki Murase, Pilgrim J Jackson, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 6, 2011
Towards a modern definition of vitamin E-evidence for a quinone hypothesis
William D Shrader, Akiko Amagata, Adam Barnes, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 24, 2011
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging
William D Shrader, Akiko Amagata, Adam Barnes, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Clinical Pharmacology in Drug Development
|
December 8, 2022
Clinical Drug-Drug Interaction Between Vatiquinone, a 15-Lipoxygenase Inhibitor, and Rosuvastatin, a Breast Cancer Resistance Protein Substrate
Lucy Lee, Katsuyuki Murase, Jiyuan Ma, et al.
European Journal of Clinical Pharmacology
|
September 27, 2022
Evaluation of vatiquinone drug-drug interaction potential in vitro and in a phase 1 clinical study with tolbutamide, a CYP2C9 substrate, and omeprazole, a CYP2C19 substrate, in healthy subjects
Katsuyuki Murase, Lucy Lee, Jiyuan Ma, et al.
Journal of Clinical Pharmacology
|
September 23, 2024
Determination of Vatiquinone Drug-Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
Lucy Lee, Noriko Okudaira, Katsuyuki Murase, et al.
Biopharmaceutics & Drug Disposition
|
September 16, 2025
Enhanced Vatiquinone Bioavailability With Fatty Meals and Optimal Dosing Schedule
Lucy Lee, Katsuyuki Murase, Martin Thoolen, et al.
Chemistry & Biology
|
March 6, 2003
EF-Tu binding peptides identified, dissected, and affinity optimized by phage display
Katsuyuki Murase, Kim L Morrison, Phillip Y Tam, et al.
ACS Chemical Biology
|
July 3, 2007
Double barrel shotgun scanning of the caveolin-1 scaffolding domain
Aron M Levin, Katsuyuki Murase, Pilgrim J Jackson, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 6, 2011
Towards a modern definition of vitamin E-evidence for a quinone hypothesis
William D Shrader, Akiko Amagata, Adam Barnes, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 24, 2011
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging
William D Shrader, Akiko Amagata, Adam Barnes, et al.
Page
of 1